UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Clinical trials for UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive microsphere injection tested as new weapon against inoperable liver cancer
Disease control Recruiting nowThis early-phase study is testing a single injection called MDN-001, which contains tiny radioactive spheres, for people with liver cancer that cannot be removed by surgery. The main goals are to see if the treatment is safe and if it can shrink tumors. Researchers will enroll ab…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1 • Sponsor: Suzhou Mednovo Yi Medical Technology Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for liver cancer patients in Resource-Limited settings
Disease control Recruiting nowThis study aims to find out if combining a targeted procedure (TACE) with a cancer drug (lenvatinib) works better than the drug alone for treating advanced liver cancer that cannot be surgically removed. It will involve 40 patients and focuses on real-world settings where access …
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC